• Company
    • Craneware At-a-Glance
    • Craneware Partners and Sponsorships
    • Craneware Health (UK)
    • Craneware’s Executive Leadership
    • History
    • Offices
    • Contact Us
  • Careers
  • Investors
    • Corporate governance
    • Share Information
    • Directors
    • Financial Reports and Presentations
    • History
    • Announcements
    • AIM Rule 26
    • Advisors & Contacts
  • Login
    • Online Reference Toolkit®
    • Reference Plus™
    • InSight products
CranewareCranewareCranewareCraneware
  • Home
  • What We Do
    • Patient Engagement
      • InSight Medical Necessity®
      • InSight Medical Necessity® MEDITECH
      • Trisus® Patient Payment
      • Patient Charge Estimator®
    • Charge Capture & Pricing
      • Chargemaster Toolkit®
      • Chargemaster Toolkit® Discovery Viewer
      • Chargemaster Toolkit® Corporate Discovery Viewer
      • Chargemaster Toolkit® – CAH
      • Reference Plus™
      • Online Reference Toolkit®
      • Physician Revenue Toolkit®
      • Pricing Analyzer™
      • Pharmacy ChargeLink®
      • Supplies ChargeLink®
      • Supplies Assistant
      • Interface Scripting Module
    • Claims Analysis
      • Trisus® Claims Informatics
    • Revenue Recovery & Retention
      • InSight Audit®
      • InSight Denials®
    • Cost Analytics
    • Professional Services
      • Revenue Integrity Package
      • Chargemaster Review
      • Pricing Analysis Review
      • Appeal Services
  • Learning
    • Blog
    • Case Studies
    • White Papers
    • RAC Audit Resources
    • Craneware Insights Articles
    • Webinar Library
    • Craneware Performance Center
    • Join Support Session
  • News & Events
    • Financial Performance Summit
    • Webinars & Upcoming Events
    • Press Releases
    • Articles & Publications

Trading Update – 10 January 2012

    Home Trading Update – 10 January 2012

    10 January 2012 – Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market provides an update on trading for the six month period ended 31 December 2011 and confirms the opportunity pipeline supports full year market expectations. The Company also announces a new channel partner agreement.

    Trading Update


    Overall the Group expects to report an increase in revenues in the first half of the year of over 12% (H1 FY11:$16.6m) and adjusted EBITDA1 in line with the corresponding period last year (H1 FY11:$4.6m). These results include, for the first time, a full six months contribution from Craneware InSight, Inc. Excluding Craneware InSight, adjusted EBITDA for the period would have increased by over 15%.

    Despite continued development of opportunities and growth in the sales pipeline during the period, we have seen sales cycles extend for all the Group’s product families. The Board believes this is due to an unexpectedly high percentage of healthcare providers choosing to focus on achieving the 31 December 2011 deadline for the first Electronic Health Records Incentive Payments. With this first deadline now having passed, and far fewer US hospitals remaining to apply in 2012, the Board expects sales cycles to return to normal lengths. As pressure mounts on all US hospitals to rectify the underlying causes of the Recovery Audit Contractors’ findings, thereby avoiding further fines and penalties, the Board further believes the focus of hospitals will once again return to Revenue Integrity Solutions which provide the underlying return on Invested Capital for the Electronic Health Records.

    Craneware InSight

    Craneware InSight, the wholly owned subsidiary of Craneware plc acquired on 17 February 2011 has had mixed results during the six months to 31 December 2011. Despite achieving initial new sales including cross selling into the existing Craneware customer base, revenue and adjusted EBITDA1 are behind the Board’s expectations. A significant factor to this is the cessation of a contract administered through a third party, resulting from that third party losing its contract with the end hospital network. The Company is currently in discussions with the new administering agents of the hospital network to replace these contracts. However, this has negatively impacted Group adjusted EBITDA1 by approximately $0.7m during the period and is currently subject to legal review by Craneware as it examines its options to enforce its contractual rights and remedies.

    The integration of Craneware InSight is well advanced with consistent branding across the organisation, new amalgamated products in development and significant sales pipeline opportunities for both product sets into the respective customer bases.

    Contract win

    The Group has continued to progress a number of large channel partner agreements during the period, with one signed at the end of the period. This agreement includes a significant minimum payment for software licenses to be paid to Craneware for each of the next three years. The channel partner will be re-packaging and re-selling Craneware proprietary technology and data to hospitals in a non-competitive parallel segment to that in which Craneware operates. Due to the nature of this specific agreement it has not impacted these reported results, with all associated revenues being recognised in the second half of this fiscal year and beyond.

    First in KLAS

    In December 2011, in the “2011 Best in KLAS Awards: Software & Services” report from the prestigious U.S. IT healthcare industry research group, KLAS, Craneware’s Bill Analyzer was named as a new KLAS revenue cycle market category leader and Chargemaster Toolkit® was named in its category, number 1 for the sixth consecutive year . This research is based entirely on user feedback and demonstrates the continued high quality of Craneware’s core product offerings.

    Outlook

    Looking ahead to the second half, in addition to our substantial sales pipeline, we are making significant progress with a number of large channel partner opportunities. With these channel partner opportunities we are able, where appropriate, to substantially complete the associated implementation and professional services engagements in advance, as proof of concept. This results in the recognition of the associated revenues on contract signing, in line with our normal policy of recognising professional services revenues based on their percentage completion. This combined with the overall size of the individual agreements themselves, provides the Board with confidence in its ability to meet market expectations for both revenue and adjusted EBITDA for the full year.

    Craneware will be announcing its Interim Results on Tuesday 28 February 2012.

    Keith Neilson, CEO of Craneware plc commented:

    “Whilst this has been a challenging trading period for the Group, the strength of our product suite, as demonstrated by our number 1 positioning in the KLAS reports, means we are well placed to help our customers deal with their increasing fiscal and regulatory pressures as fines and recoveries from the Recovery Audit Contractors appear on their public financial statements for the first time. This combined with the size of our opportunity pipeline means we continue to look to the future with confidence.”

    1. Adjusted EBITDA is profit before share based payments, depreciation, amortization and acquisition related costs.

    For further information, please contact:

    Craneware plc

    • +44 (0)131 550 3100
    • Keith Neilson, CEO
    • Craig Preston, CFO

    Peel Hunt

    • +44 (0)20 7418 8900
    • Dan Webster
    • Richard Kauffer

    Newgate Threadneedle

    • +44 (0)20 7653 9850
    • Caroline Evans-Jones
    • Fiona Conroy
     

    About Craneware

    Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta and Arizona, employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for healthcare organisations. Craneware’s market-driven, annuity SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. These optimise reimbursement, increase operational efficiency and minimize compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

    Let’s Talk

    Request a demo

    Follow Us

    Accolades

    #1 in KLAS since 2006

    KLAS LogoChargemaster Toolkit® is ranked No.1 in the Chargemaster Management category for the twelfth year in a row (2006 – 2018.) in the "2018 Best in KLAS Awards: Software & Services" report, published January 2018. Data © 2017 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com www.KLASresearch.com

    Peer Reviewed by HFMA®

    HFMA Peer Review Logo*HFMA staff and volunteers determined that Craneware's Chargemaster Toolkit® has met specific criteria developed under the HFMA Peer Review Process. HFMA does not endorse or guarantee the use of these products.

    3340 Peachtree Rd. NE, Suite 850, Atlanta, GA 30326

      support@craneware.com

    +877 624 2792

    About Craneware

    Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The company’s flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle – Chargemaster Management since 2006 and is part of our value cycle management suite, which includes Patient Engagement, Charge Capture & Pricing, Coding Integrity, Revenue Recovery & Retention, and Cost Analytics solutions.

    Copyright 2017 | Craneware, Inc. | All Rights Reserved
    • 3 of the Most Common Charge Capture Errors
      • Thank you for downloading
    • 5 Keys to Getting Started with Charge Capture Audits
      • Thank you for downloading
    • 7 Statistics You Need To Know About Charge Capture
      • Thank you for downloading
    • Accolades
    • AHRMM17
    • Better Outcomes For All
    • CDM Technology
      • How Current is your CDM data?
        • Download Infographic
        • Learn More
      • Learn More
    • Cerner Health Conference 2017
    • Changes in Pharmacy Cost and Reimbursement
    • Contact Craneware
    • Craneware’s blog
    • Craneware, Inc. Privacy Policy
    • Customer Services Holiday Schedule
    • Download Pricing Analysis
    • Home
    • PCL Touch
    • Pharmacy Revenue Integrity
      • Schedule a conversation with our experts
    • Pricing Analyzer™ Calculator
    • Pricing Strategy and Hospital Margins
      • Schedule a conversation with our experts
    • Request a Craneware Product Demonstration
    • Request Pricing Analysis
    • Retrospective Charge Capture Audits
    • Revenue Integrity Best Practice Sharing Session
    • Thank you for scanning our QR Code
      • Your entry has been received
    • Thank you for scanning our QR Code
      • Your entry has been received
    • Thank you for scanning our QR Code
      • Your entry has been received
    • The Value Cycle
    • What does Patient Engagement Mean to You?
    • Where Errors Can Occur In The Charge Capture Process
      • Thank you for downloading
    • Yop Poll Archive
    • Your message has been received
    • Your message has been received
    • Your message has been received
    • First Day of Dealings
    • 2018 NYC User Group
      • 2018 New York User Group Registration
    • 2018 Ohio User Group
    • ASHP Midyear
      • Thank you for your interest in ASHP Midyear
    • Financial Performance Summit
      • 2018 Craneware Financial Performance Summit Registration
        • Thank you for registering
      • Financial Performance Summit – Photos
    • HFMA ANI 2017
      • Booth Appointment
      • Thank you for visiting us at HFMA ANI 2017
    • miCheckin
    • Trading on PLUS Markets
    • What We Do
      • Chargemaster Toolkit® Corporate Discovery Viewer
      • Patient Charge Estimator®
      • Supplies Assistant
      • Trisus® Patient Payment
      • InSight Audit®
      • InSight Medical Necessity®
      • InSight Medical Necessity® MEDITECH
      • Trisus® Claims Informatics
      • InSight Denials®
      • Interface Scripting Module
      • Patient Engagement Solutions
      • Chargemaster Toolkit® Discovery Viewer
      • Revenue Recovery & Retention
      • Charge Capture & Pricing
      • Pricing Analyzer™
      • Physician Revenue Toolkit®
      • Online Reference Toolkit®
      • Reference Plus™
      • Chargemaster Toolkit® – CAH
      • Chargemaster Toolkit®
      • Craneware Healthcare Intelligence
        • Contact Craneware Healthcare Intelligence
        • About Craneware Healthcare Intelligence
        • CHI Leadership
      • Trisus®
      • Pharmacy ChargeLink®
      • Supplies ChargeLink®
    • Learning
      • All Insights Articles
        • January 2015 Integrated Outpatient Code Editor (I/OCE) Specifications Version 16.0
      • Chargemaster Review: Step-by-Step Process for a Clean CDM
      • Craneware Case Studies
      • Getting Clinical Departments Engaged in the CDM Review Process
      • Physician Specialty Pricing Report
        • Your form submission has been received
      • Your message has been received
      • RAC Audit Resources
      • Craneware White Papers
        • Revenue Integrity in Healthcare
        • Supply Chain and Revenue Cycle Integration
        • Three Ways to Overcome Chargemaster Review Roadblocks
        • Chargemaster Automation: A Strategic Asset for Achieving Revenue Integrity
        • RAC Best Practices: Utilization Management
        • Building a Better Chargemaster With Supply Data Integration
        • RAC Best Practices: Medical Record Preparation and Submission
      • Webinar Library
      • JW Modifier FAQ and Drug List Download
    • Professional Services
      • Appeal Services
      • Pricing Analysis Review
      • Chargemaster Review
      • Revenue Integrity Package
    • Annual Report & Accounts
    • Company
      • Craneware At-a-Glance
      • Offices
        • Needham Office
        • Pittsburgh Office
        • Scottsdale Office
        • Edinburgh Office
        • Atlanta Office
      • Craneware Partners and Sponsorships
      • Executive Leadership
      • Careers
    • Investors Documents
    • Investors
      • AIM Rule 26
        • AIM Securities Information
        • Documents
        • Strategy
        • Advisors
        • Announcements
        • Financial Reports and Presentations
      • Directors
        • Russ Rudish
        • Colleen M. Blye
        • Ron F. Verni
        • Craig T. Preston
        • Keith Neilson
        • George R. Elliott
      • History
      • Corporate governance
    • News & Events
      • Press Releases
        • Press Releases – 2015
      • Webinars & Upcoming Events
      • Articles & Publications
        • Articles & Publications – 2014
        • Articles & Publications – 2015
        • Articles & Publications – 2016
        • Articles & Publications – 2017
        • Articles & Publications – 2013
        • Articles & Publications – 2012
    • Block Listing
    • Dividend Declaration
    • Trading Update – 11 January 2008
    • Director Shareholding – 9 September 2010
    • October 2009 Blocklisting Interim Review
    • Dividend Currency Election – 6 November 2009
    • Grant of Options – 23 December 2009
    • Dividend Currency Election – 5 March 2010
    • 15th April 2010 Blocklisting
    • Additional Listing – 15 March 2011
    • Notice of Interim Results
    • Reseller Agreement with Premier
    • Total Voting Rights – 28 April 2011
    • Director Declaration
    • Director Shareholding Amendment
    • Interim Results
    • Total Voting Rights – 01 June 2011
    • Investor and Analyst Presentation
    • Launch of ADR Programme
    • Craneware InSight Contract Win
    • Trading Update – 30 June 2010
    • Holding(s) in Company – 07 June 2011
    • Notice of Final Results
    • Price Monitoring Extension – 19 August 2011
    • Second Price Monitoring Extn – 19 August 2011
    • Price Monitoring Extension – 22 August 2011
    • Second Price Monitoring Extn – 22 August 2011
    • Holding(s) in Company – 22 August 2011
    • Director Shareholding – 31 August 2011
    • Result of AGM 2010
    • Dividend Currency Election – 12 November 2010
    • Grant of Options – 26 September 2011
    • Adviser – Change of Name
    • Total Voting Rights – 21 October 2011
    • Holding(s) in Company – 28 January 2011
    • Posting of Annual Report & Notice of AGM
    • Trading Update – 10 July 2008
    • Acquisition of ClaimTrust
    • Director Shareholding – 25 October 2011
    • Holding(s) in Company – 10 March 2011
    • Total Voting Rights – 01 November 2011
    • Additional Listing – 14 March 2011
    • AGM Statement – 10 November 2011
    • Result of AGM
    • Appointment of a Director
    • Blocklisting Interim Review – 01 November 2011
    • Total Voting Rights – 31 March 2011
    • Trading Update – 10 January 2012
    • Holding(s) in Company – 11 January 2012
    • Holding(s) in Company – 6 April 2011
    • Blocklisting Application
    • Holding(s) in Company – 16 January 2012
    • 2008 Annual Report and Notice of AGM
    • Holding(s) in Company – 31 January 2012
    • Price Monitoring Extension – 20 April 2011
    • Holding(s) in Company – 27 April 2011
    • Blocklisting Interim Review – 27 April 2011
    • Holding(s) in Company – 20 February 2012
    • Half Yearly Report
    • Channel Partner Contract Win
    • Total Voting Rights – 27 April 2012
    • AGM Statement 2012
    • Result of AGM 2012
    • Dividend Currency Election – 9 November 2012
    • Notice of Results – 23 February 2009
    • 2009 Annual Report and Notice of AGM
    • Help
    • Notice of Results – 01 February 2012
    • Terms & Conditions
    • Total Voting Rights
    • Total Voting Rights – 13 August 2012
    • Dividend Currency Election – 18 March 2013
    • Result of AGM
    • Total Voting Right – 15 April 2013
    • Application Submission Confirmation
    • Schedule a conversation
    Craneware
    • Home
    • What We Do
      ▼
      • Patient Engagement
        ▼
        • InSight Medical Necessity®
        • InSight Medical Necessity® MEDITECH
        • Trisus® Patient Payment
        • Patient Charge Estimator®
      • Charge Capture & Pricing
        ▼
        • Chargemaster Toolkit®
        • Chargemaster Toolkit® Discovery Viewer
        • Chargemaster Toolkit® Corporate Discovery Viewer
        • Chargemaster Toolkit® – CAH
        • Reference Plus™
        • Online Reference Toolkit®
        • Physician Revenue Toolkit®
        • Pricing Analyzer™
        • Pharmacy ChargeLink®
        • Supplies ChargeLink®
        • Supplies Assistant
        • Interface Scripting Module
      • Claims Analysis
        ▼
        • Trisus® Claims Informatics
      • Revenue Recovery & Retention
        ▼
        • InSight Audit®
        • InSight Denials®
      • Cost Analytics
      • Professional Services
        ▼
        • Revenue Integrity Package
        • Chargemaster Review
        • Pricing Analysis Review
        • Appeal Services
    • Learning
      ▼
      • Blog
      • Case Studies
      • White Papers
      • RAC Audit Resources
      • Webinar Library
      • Craneware Performance Center
      • Join Support Session
    • News & Events
      ▼
      • Financial Performance Summit
      • Webinars & Upcoming Events
      • Press Releases
      • Articles & Publications
    • Company
      ▼
      • Craneware At-a-Glance
      • Craneware Partners and Sponsorships
      • Craneware Health (UK)
      • Craneware’s Executive Leadership
      • History
      • Offices
      • Contact Craneware
    • Careers
    • Investors
      ▼
      • Corporate governance
      • Share Information
      • Directors
      • Financial Reports and Presentations
      • History
      • Announcements
      • AIM Rule 26
      • Advisors & Contacts
    • Login
      ▼
      • Online Reference Toolkit®
      • Reference Plus™
      • InSight products